An observational study in HIV Infections and Elderly Infection, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-15.
Sponsored by Chinese University of Hong Kong · Observational
This qualitative study aims to explore lived experiences of older adults living with HIV in Hong Kong. Twenty older Chinese adults of age 50 or above will be recruited from an HIV specialist clinic providing HIV care in the public service. Qualitative, semi-structured interview will be conducted to explore risk factors contributing to life stress and adversity, and protective factors associated with resilience. The qualitative data will be delineated to propose a typology of older adults living with HIV as characterized by their unmet needs, barriers and facilitators of resilience-building.
Objectives: The intersection of HIV and ageing has important implications for health and psychosocial wellbeing, which are complex in nature. In a setting with growing number of older adults living with HIV in Hong Kong, as in many other regions in the world, addressing their unmet healthcare needs is paramount. Failure to understand and recognise their needs will impede healthy ageing. This study aims to explore lived experiences of older adults living with HIV in regards their complex needs and resilience-building, with the specific objectives of examining associated factors of resilience development at individual-social- and structural level.
Design: A qualitative study targeting 20 older Chinese adults of age 50 or above who are living with HIV who are divided under the following groups: Group A: Chinese men who have sex with men and Group B: Chinese heterosexual males and females
Settings: Clinic providing HIV care in the public service
Methods: Participants will be recruited through purposive sampling based on their age (50-64; 65 and above of age), gender and sexual orientation. Qualitative, semi-structured interview will be conducted to explore: (1) risk factors contributing to life stress and adversity, and (2) protective factors associated with resilience. Interviews will be digitally recorded, transcribed verbatim and managed using "NVivo" software. Themes will be developed, constantly compared within and between targeted groups, using Grounded Theory approach.
Anticipated outcomes:
The qualitative data will be delineated to propose a typology of older adults living with HIV as characterized by their (1) unmet needs, (2) barriers of resilience-building, and (3) facilitators of resilience-building.
4,340 studies on the registry are indexed under HIV Infections; 240 are open to participants now.
This study's enrollment of 20 is below the median of 200 across 731 observational studies indexed under HIV Infections.
Browse HIV Infections studies →Chinese University of Hong Kong is the lead sponsor of 1,446 studies on the registry; 467 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Older adults living with HIV infection in Hong Kong
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Chinese men who have sex with men living with HIV infection and attending the service of HIV specialist service in Hong Kong
Other: no intervention
Chinese heterosexual men and women living with HIV infection and attending the service of HIV specialist service in Hong Kong
Other: no intervention
No intervention involved
risk items
risk factors contributing to stress and adversity
Time frame: 1 year
protective factors
Factors associated with resilience
Time frame: 1 year
Plan to share: No — The descriptive data could only be accessed by the investigators and the research team, in line with the ethics approval obtained.
No publications or documents are linked to this record.
Ran from Nov 2021 to primary completion in Apr 2023, 17 months.
Of 183 non-industry observational studies under HIV Infections, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's 17 months is below that.
Counting every sponsor, half of 204 studies reached it within 38 months; a quarter within 17 and three quarters within 68.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong →